A novel real-time PCR assay system was developed to quantify the cytomegalo
virus (CMV) genome load. The real-time PCR assay could detect from 6 to ove
r 10(6) copies of CMV-DNA with a wide linear range. The virus load of immun
ocompromised patients with symptomatic CMV infections was quantified and co
mpared to that of asymptomatic ones. In symptomatic patients, all 17 periph
eral blood leukocytes were positive for CMV DNA, and its mean value was 10(
3.3) copies/10(6) cells. On the other hand, only 9 of 38 samples (24%) were
positive in the asymptomatic patients, and its mean titer was lower (10(2.
0) copies/10(6) cells) than that of the symptomatic group (P = 0.002). In p
lasma, the virus genome was detected in 13 out of 17 samples from symptomat
ic patients (76%), and its mean value was 10(4.0) copies/ml. In contrast, f
or the asymptomatic group, only one out of 36 samples were positive (3%). F
inally, this system was used to monitor two patients with CMV infections se
rially. The CMV DNA copy number changed with their clinical symptoms and an
ti-CMV therapy, and virtually paralleled the result of the pp65 antigenemia
assay in both cases. In one patient with the cord blood transplantation, h
owever, the CMV DNA became positive faster than the antigenemia assay. Thes
e results indicate that this assay is sensitive and useful for estimating t
he CMV genome load not only in peripheral blood leukocytes but also in plas
ma. It can be very helpful for diagnosing CMV-related diseases and monitori
ng the virus load in patients with CMV infections. J. Med. Virol. 60:455-46
2, 2000. (C) 2000 Wiley-Liss, Inc.